APA (7th ed.) Citation

Conley, T. E., Duncan, A., Modasia, A., Ford, A. C., Pritchard, D. M., Hildebrand, F., . . . Probert, C. S. (2026). The Emerging Short Chain Fatty Acid Enriched Metabotype in Irritable Bowel Syndrome and Its Potential Clinical Relevance. Alimentary Pharmacology & Therapeutics, 64(2), 208. https://doi.org/10.1111/apt.70677

Chicago Style (17th ed.) Citation

Conley, T. E., A. Duncan, A. Modasia, A. C. Ford, D. M. Pritchard, F. Hildebrand, F. J. Warren, R. Spiller, and C. S. Probert. "The Emerging Short Chain Fatty Acid Enriched Metabotype in Irritable Bowel Syndrome and Its Potential Clinical Relevance." Alimentary Pharmacology & Therapeutics 64, no. 2 (2026): 208. https://doi.org/10.1111/apt.70677.

MLA (9th ed.) Citation

Conley, T. E., et al. "The Emerging Short Chain Fatty Acid Enriched Metabotype in Irritable Bowel Syndrome and Its Potential Clinical Relevance." Alimentary Pharmacology & Therapeutics, vol. 64, no. 2, 2026, p. 208, https://doi.org/10.1111/apt.70677.